Commission on Cancer bestows Karmanos with highest accreditation for cancer care
Thursday, November 11, 2010
The American College of Surgeons (ACS) Commission on Cancer (CoC) has distinguished the Barbara Ann Karmanos Cancer Institute with a three-year accreditation with commendations for its commitment to maintaining high quality treatment programs and its multidisciplinary approach to treating cancer patients.
The three-year accreditation with commendations is the CoC’s highest level of accreditation. It is awarded when a health organization complies with all 36 commission standards. By reaching the highest accreditation level, Karmanos will also be evaluated on its eligibility to receive the CoC’s Outstanding Achievement Award.
“At Karmanos, our doctors and staff are dedicated to providing a full range of diagnostic and cancer treatment services,” said Gerold Bepler, M.D., Ph.D., president and CEO of the Institute. “Patients can be assured they are being treated by oncology physicians with specialty certification and that they have a multidisciplinary team of doctors who meet regularly to discuss their specific treatment path.
“The CoC’s Cancer Program promotes the use of a multidisciplinary consultation approach and their staff, much like ours, believes that multidisciplinary cooperation results in improved patient care.”
The CoC makes its decisions on whether to grant accreditation to a health organization based on five criteria:
- Clinical services provide state-of-the-art pre-treatment evaluation, staging, treatment and clinical follow-up for cancer patients seen at the facility.
- The organization’s cancer committee leads the program by setting goals, monitoring activity, evaluating patient outcomes and improving care.
- Cancer conferences (or Multi-Disciplinary Team meetings) provide a forum for patient consultation and contribute to physician education.
- The quality improvement program provides the forum to evaluate and improve patient outcomes.
- The cancer registry and database is the basis for monitoring the quality of care.
Besides meeting these criteria, Karmanos was commended for participating in both basic and clinical research to create the newest standards of cancer care, as well as its “exceptional” level of patient recruitment in clinical trials.
Karmanos’ additional commendations were for:
- The high number of published scientific research abstracts.
- The very high level of patient follow-up within the last five years (above 98 percent).
- The multiple screening and early-detection programs that are offered.
- Attendance by all medical staff at a national meeting during the survey period.
- The multiple, annual improvements that are made by staff within the cancer center.
The CoC, established in 1922, strives to reduce the morbidity and mortality of cancer through education; sets cancer care standards; and monitors quality care. In the 1930s, the commission established standards, a review program and cancer program accreditation. The commission continues to promote and support multidisciplinary care and overall quality improvements through its standards.